Cozaar vs. Lexapro: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Cozaar and Lexapro. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 381,860 people who take Cozaar and Lexapro, and is updated regularly.
What is Cozaar?
Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.
What is Lexapro?
Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
381,860 people who take Cozaar and Lexapro are studied.
Drugs being compared in this study:
- Cozaar (losartan potassium)
- Lexapro (escitalopram oxalate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Cozaar:
- not at all: 2.05 %
- somewhat: 16.34 %
- moderate: 38.67 %
- high: 33.9 %
- very high: 9.05 %
Lexapro:
- not at all: 3.96 %
- somewhat: 19.11 %
- moderate: 37.05 %
- high: 29.76 %
- very high: 10.11 %
Want to compare Cozaar with Lexapro?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Cozaar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lexapro:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on losartan potassium and escitalopram oxalate (the active ingredients of Cozaar and Lexapro, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nplate and Thrombocytopenia for Boys aged 10-19 - 2 seconds ago
- Nplate and Low Platelet Count for Boys aged 10-19 - 3 seconds ago
- Nplate and Platelet Count Decreased for Boys aged 10-19 - 3 seconds ago
- Nplate and Thin Blood for Boys aged 10-19 - 3 seconds ago
- Nplate and Low Blood Platelet Count for Boys aged 10-19 - 4 seconds ago
- Drug interactions of Apidra and Ultram - 4 seconds ago
- Could Prednisone cause Lactose Intolerance? - 8 seconds ago
- Could Xanax cause Mononeuritis Multiplex? - 9 seconds ago
- Could Afinitor cause Conjunctivitis? - 9 seconds ago
- Tylenol and Rhinitis for Women aged 30-39 - 13 seconds ago